Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Sci Rep ; 7(1): 5466, 2017 07 14.
Artículo en Inglés | MEDLINE | ID: mdl-28710425

RESUMEN

Inflammatory preconditioning is a mechanism in which exposure to small doses of inflammatory stimuli prepares the body against future massive insult by activating endogenous protective responses. Phospholipase A2/5-lipoxygenase/leukotriene-B4 (PLA2/5-LOX/LTB4) axis is an important inflammatory signaling pathway. Naja sputatrix (Malayan spitting cobra) venom contains 15% secretory PLA2 of its dry weight. We investigated if Naja sputatrix venom preconditioning (VPC) reduces surgical brain injury (SBI)-induced neuroinflammation via activating PLA2/5-LOX/LTB4 cascade using a partial frontal lobe resection SBI rat model. Naja sputatrix venom sublethal dose was injected subcutaneously for 3 consecutive days prior to SBI. We observed that VPC reduced brain edema and improved neurological function 24 h and 72 h after SBI. The expression of pro-inflammatory mediators in peri-resection brain tissue was reduced with VPC. Administration of Manoalide, a PLA2 inhibitor or Zileuton, a 5-LOX inhibitor with VPC reversed the protective effects of VPC against neuroinflammation. The current VPC regime induced local skin inflammatory reaction limited to subcutaneous injection site and elicited no other toxic effects. Our findings suggest that VPC reduces neuroinflammation and improves outcomes after SBI by activating PLA2/5-LOX/LTB4 cascade. VPC may be beneficial to reduce post-operative neuroinflammatory complications after brain surgeries.


Asunto(s)
Araquidonato 5-Lipooxigenasa/metabolismo , Lesiones Encefálicas/tratamiento farmacológico , Encéfalo/patología , Venenos Elapídicos/uso terapéutico , Inflamación/tratamiento farmacológico , Complicaciones Intraoperatorias/tratamiento farmacológico , Leucotrieno B4/metabolismo , Fosfolipasas A2/metabolismo , Animales , Biomarcadores/metabolismo , Edema Encefálico/complicaciones , Edema Encefálico/tratamiento farmacológico , Edema Encefálico/patología , Edema Encefálico/fisiopatología , Lesiones Encefálicas/sangre , Lesiones Encefálicas/patología , Lesiones Encefálicas/fisiopatología , Venenos Elapídicos/farmacología , Hidroxiurea/administración & dosificación , Hidroxiurea/análogos & derivados , Hidroxiurea/farmacología , Complicaciones Intraoperatorias/sangre , Complicaciones Intraoperatorias/patología , Complicaciones Intraoperatorias/fisiopatología , Recuento de Leucocitos , Inhibidores de la Lipooxigenasa/administración & dosificación , Inhibidores de la Lipooxigenasa/farmacología , Naja , Inhibidores de Fosfolipasa A2/administración & dosificación , Inhibidores de Fosfolipasa A2/farmacología , Ratas , Transducción de Señal , Piel/patología , Tejido Subcutáneo/patología , Terpenos/administración & dosificación , Terpenos/farmacología
2.
Acta Neurochir Suppl ; 121: 305-10, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26463966

RESUMEN

Surgically induced brain injury (SBI) results in brain edema and neurological decline. Valproic acid (VA) has been shown to be neuroprotective in several experimental brain diseases. In this study, we investigated the pretreatment effect of VA in a rat model of SBI. A total of 57 male Sprague-Dawley rats were use in four groups: sham, SBI + vehicle, SBI + low dose (100 mg/kg) VA, and SBI + high dose (300 mg/kg) VA. SBI was induced by partially resecting right frontal lobes. Shams underwent identical surgical procedures without brain resection. VA or vehicle was administered subcutaneously 30 min prior to SBI. At 24 and 72 h post SBI, neurobehavior and brain water content were assessed as well as matrix metalloproteinases (MMPs) activities. There was significantly higher brain water content within the right frontal lobe in SBI rats than in shams. Without neurobehavioral improvements, the low-dose but not high-dose VA significantly reduced brain edema at 24 h post SBI. The protection tends to persist to 72 h post SBI. At 24 h post SBI, low-dose VA did not significantly reduce the elevated MMP-9 activity associated with SBI. In conclusion, VA pretreatment attenuated brain edema at 24 h after SBI but lacked MMP inhibition. The single dose VA was not associated with neurobehavioral benefits.


Asunto(s)
Conducta Animal/efectos de los fármacos , Edema Encefálico/fisiopatología , Lesiones Encefálicas/fisiopatología , Encéfalo/efectos de los fármacos , Inhibidores Enzimáticos/farmacología , Procedimientos Neuroquirúrgicos , Ácido Valproico/farmacología , Animales , Edema Encefálico/etiología , Edema Encefálico/metabolismo , Edema Encefálico/patología , Lesiones Encefálicas/complicaciones , Lesiones Encefálicas/metabolismo , Lesiones Encefálicas/patología , Modelos Animales de Enfermedad , Lóbulo Frontal/cirugía , Complicaciones Intraoperatorias , Metaloproteinasa 2 de la Matriz/efectos de los fármacos , Metaloproteinasa 2 de la Matriz/metabolismo , Metaloproteinasa 9 de la Matriz/efectos de los fármacos , Metaloproteinasa 9 de la Matriz/metabolismo , Ratas , Ratas Sprague-Dawley
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA